Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib +/- Dacarbazine in Metastatic Melanoma
NCT00615160Phase 2Terminated
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in melanoma. Started Dec 2006; status: terminated.
02
Drugs
vatalanib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00615160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615160.